drugset
drugset / Trial / NCT03881306

DEBOXA for Inoperable NET Liver Metastases

NCT03881306 ↗

Phase 1/2 Unknown 60 enrolled Xiangya Hospital of Central South University
NaSingle-groupOpen-labelTreatment

Summary

A prospective clinical trial to study the safety and effectiveness of Transcatheter Artery Chemotherapy and Embolization (TACE) using CalliSpheres Drug-Eluting Beads with oxaliplatin (DEBOXA) in treating patients who have inoperable neuroendocrine neoplasm (NEN) liver metastases.

Timeline

Start
2018-07-01
Primary completion
2020-12-31
Completion
2021-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxaliplatin Small molecule — —

Indications

metastatic neoplasm neuroendocrine neoplasm